Clinical Trials Logo

Glutamine clinical trials

View clinical trials related to Glutamine.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02738762 Withdrawn - Clinical trials for Mechanical Ventilation

Glutamine Supplementation

Start date: November 15, 2017
Phase: N/A
Study type: Interventional

Earlier studies showed a benefit in survival when glutamine was given intravenously and these studies lead to recommendations that glutamine should be given to critically ill patients. The ESPEN guidelines recommend 0,2-0,4 g/kg/d intravenous glutamine added to standard parenteral nutrition . Until recently it was not possible to obtain a plasma glutamine level fast enough to consider the result for clinical decision making. With the availability of a Point of Care (POCT) measurement of plasma glutamine level a measurement can be performed short after the collection of blood. This offers the possibility to identify a patient with a low plasma glutamine level shortly after admission and use repeated measurements for evaluation of the response to supplementation of glutamine.